Frailty, Physical Capacity and Lung Function in Postoperative Pulmonary Endarterectomy Patients
Launched by UNIVERSITY OF SAO PAULO GENERAL HOSPITAL · Feb 23, 2024
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how surgery for chronic thromboembolic pulmonary hypertension (a condition that affects the lungs and causes high blood pressure) impacts patients’ physical abilities and lung function after the surgery. Specifically, researchers want to see how physical performance, lung capacity, and muscle strength change in patients who have undergone a procedure called pulmonary endarterectomy (PET), which helps improve blood flow in the lungs.
To participate in this study, individuals must be at least 18 years old and scheduled for elective pulmonary endarterectomy surgery. They should not have any cognitive issues or significant motor problems that would prevent them from completing tests about their physical abilities before and after the surgery. Participants will be monitored for changes in their physical and lung health during their recovery. This research aims to help doctors understand how to better support patients’ recovery and improve their quality of life after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years
- • Both genders
- • Elective pulmonary endarterectomy surgery
- • Absence of cognitive or peripheral motor impairment that prevents the performance of functional tests in the preoperative period.
- Exclusion Criteria:
- • Reoperation for any reason
- • Presence of cognitive or peripheral motor impairment that prevents the performance of functional tests in the postoperative period.
About University Of Sao Paulo General Hospital
The University of São Paulo General Hospital (Hospital das Clínicas da Universidade de São Paulo) is a leading clinical research institution in Brazil, renowned for its commitment to advancing medical knowledge and patient care. As an academic hospital affiliated with one of the largest and most prestigious universities in Latin America, it integrates clinical practice, education, and research. The hospital conducts a wide array of clinical trials across various medical disciplines, aiming to develop innovative therapies and improve healthcare outcomes. With a multidisciplinary team of healthcare professionals and access to cutting-edge facilities, the University of São Paulo General Hospital is dedicated to fostering scientific advancements and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
São Paulo, Sp, Brazil
Patients applied
Trial Officials
Rafael M Ianotti, PT
Principal Investigator
Instituto do Coração - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported